[1]
“Duvyzat (Givinostat) in Duchenne Muscular Dystrophy: Mechanisms, Clinical Impact, and Future Directions”, CPR, vol. 1, no. 3, pp. 308–322, Oct. 2025, doi: 10.63785/cpr.2025.1.3.308322.